Floatz logo

Irradiated Allogeneic Cells

JAK2 Gene Mutation

Rutgers, The State University of New JerseyCell therapyEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the JAK2 Gene Mutation cohort.

Asset / SponsorPhaseRating
Imatinib
M.D. Anderson Cancer Center
Phase 2B
Letrozole
M.D. Anderson Cancer Center
Phase 2B

Same molecule, other indications

Irradiated Allogeneic Cells is also rated in:

acute myeloid leukemiaDormant
C
Indicative ·
39 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
C
Indicative ·
39 / 100
View asset →
chromosome 17p deletionDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →